web analytics
26.3 C
Munich
Thursday, June 30, 2022

TAG

CYDY

CytoDyn Inc (OTCMKTS: CYDY) On the Comeback Trail (HIV Leronlimab Update)

CytoDyn Inc (OTCMKTS: CYDY) continues to move steadily higher in recent trading since hitting lows of $0.231 after the FDA placed a partial clinical...

CytoDyn Inc (OTCMKTS: CYDY) Major Reversal Brewing after Biotech Looks for Positive Outcome of Clinical Hold on HIV program

CytoDyn Inc (OTCMKTS: CYDY) is moving northbound after another test of $0.23 lows. The stock was one of the biggest runners of 2020 skyrocketing...

Todos Medical (TOMDF) & CYDY are Two Biotech Plays to Watch Monday After the Merck Expose

Todos Medical (OTCMKTS: TOMDF) and CytoDyn Inc. (OTCMKTS: CYDY) might be looking at a pretty good week ahead of them.  in a recent article...

Top Covid Stocks In Play After Pfizer Vaccine Approval: TOMDF ENZC TSOI

With the FDA approval of the Pfizer-BioNTech vaccination many biotech stocks moved higher.  Leading the microcaps was Todos Medical (OTCMKTS: TOMDF).  Shares of leading...

CytoDyn’s Robust Platform Technology Keeps Expanding Into Breakthrough Therapy Designation Territory

Leronlimab is an immunomodulator that targets many diseases Multiple indications being pursued in parallel Proven safety profile, novel mechanism of action, & ease...

CytoDyn Inc (OTCMKTS: CYDY) Gaining as Vyrologix (leronlimab-PRO 140) Top Line Data Looms

CytoDyn Inc (OTCMKTS: CYDY) is making an explosive move up the charts in recent weeks on a massive wave of buy volume and heavy...

Latest news